These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10530702)
41. New role of lupeol in reticence of angiogenesis, the cellular parameter of neoplastic progression in tumorigenesis models through altered gene expression. Vijay Avin BR; Prabhu T; Ramesh CK; Vigneshwaran V; Riaz M; Jayashree K; Prabhakar BT Biochem Biophys Res Commun; 2014 May; 448(2):139-44. PubMed ID: 24780400 [TBL] [Abstract][Full Text] [Related]
42. Preclinical efficacy of anecortave acetate. Clark AF Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of angiogenesis through modulation of collagen metabolism. Ingber D; Folkman J Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830 [TBL] [Abstract][Full Text] [Related]
45. Angiogenic activity in injured rat corneas as assayed on the chick chorioallantoic membrane. Vu MT; Burger PC; Klintworth GK Lab Invest; 1985 Sep; 53(3):311-9. PubMed ID: 2412000 [TBL] [Abstract][Full Text] [Related]
46. Experimental ocular angiogenesis. Federman JL; Brown GC; Felberg NT; Felton SM Am J Ophthalmol; 1980 Feb; 89(2):231-7. PubMed ID: 6153510 [TBL] [Abstract][Full Text] [Related]
47. AL-3789: a novel ophthalmic angiostatic steroid. Clark AF Expert Opin Investig Drugs; 1997 Dec; 6(12):1867-77. PubMed ID: 15989587 [TBL] [Abstract][Full Text] [Related]
48. Inhibitory effects of clotrimazole on TNF-alpha-induced adhesion molecule expression and angiogenesis. Thapa D; Lee JS; Park MA; Cho MY; Park YJ; Choi HG; Jeong TC; Kim JA Arch Pharm Res; 2009 Apr; 32(4):593-603. PubMed ID: 19407978 [TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids. Dobričić V; Marković B; Milenković N; Savić V; Jaćević V; Rančić N; Vladimirov S; Cudina O Arch Pharm (Weinheim); 2014 Nov; 347(11):786-97. PubMed ID: 25159891 [TBL] [Abstract][Full Text] [Related]
51. Species-specific regulation of angiogenesis by glucocorticoids reveals contrasting effects on inflammatory and angiogenic pathways. Morgan R; Keen J; Halligan D; O'Callaghan A; Andrew R; Livingstone D; Abernethie A; Maltese G; Walker B; Hadoke P PLoS One; 2018; 13(2):e0192746. PubMed ID: 29447208 [TBL] [Abstract][Full Text] [Related]
52. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo. Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425 [TBL] [Abstract][Full Text] [Related]
53. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024 [TBL] [Abstract][Full Text] [Related]
54. Effects of steroidal and non steroidal drugs on the neovascularization response induced by tumoral TA3 supernatant on CAM from chick embryo. Zúñiga J; Fuenzalida M; Guerrero A; Illanes J; Dabancens A; Díaz E; Lemus D Biol Res; 2003; 36(2):233-40. PubMed ID: 14513718 [TBL] [Abstract][Full Text] [Related]
55. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats. Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822 [TBL] [Abstract][Full Text] [Related]
56. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models. Kim IT; Park HY; Choi JS; Joo CK Invest Ophthalmol Vis Sci; 2012 May; 53(6):3111-9. PubMed ID: 22491414 [TBL] [Abstract][Full Text] [Related]
57. [Inhibition of neovascularization and tumor growth by dexamethasone]. Nakamura O; Ueki K; Hibi T; Shitara N; Matsutani M; Takakura K; Oikawa T No To Shinkei; 1992 Jan; 44(1):37-41. PubMed ID: 1373288 [TBL] [Abstract][Full Text] [Related]
58. Multifocal angiostatic therapy: an update. McCarty MF; Block KI Integr Cancer Ther; 2005 Dec; 4(4):301-14. PubMed ID: 16282507 [TBL] [Abstract][Full Text] [Related]
59. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581 [TBL] [Abstract][Full Text] [Related]